Out of the 41 analysts that have coverage on Sun Pharma, 30 of them have a 'Buy' rating on the stock. Seven of them have a 'Hold' rating, while only four of them have a 'Sell' recommendation.

Most brokerages have cut earnings per share (EPS) estimates on Nestle India on the backdrop of moderation in growth momentum in the near term ...

The main drivers for Vedanta's positive outlook cited by analysts include strong performance in the aluminium, zinc, and oil ...

Following the Q3 earnings announcement, brokerages offered mixed views on the IndusInd Bank stock. Among the 50 analysts covering IndusInd Bank, 37 have a 'Buy' rating, 12 recommend 'Hold', while one ...

Leading brokerage CLSA is bullish on the stock as it said that the commissioning of projects is crucial for earnings ...

CNBC reviews Mutual of Omaha life insurance, which including term life policies up to age 80 and final expense coverage to age 85.

Premium bonds cost more than their face value. Find out how these bonds work and see if they're a worthwhile investment.

Bajaj Finance shares surged to a 52-week high, driven by strong Q3 earnings, 28% AUM growth, and a strategic Airtel ...

We ferreted out the best tech deals the internet has to offer this week and rounded them up here. Save on Sonos speakers, ...

For some, the Ford Bronco is one of the best SUVs to buy. However, the rugged off-road vehicle has seen a decline in sales. It’s also true that there have been car recalls for the Bronco, and many ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

As China’s DeepSeek continues to take the world by storm with its cheaper and more energy-efficient artificial intelligence (AI) models, companies at the forefront of the AI revolution have seen their ...